CM
EVH icon

Caption Management’s Evolent Health EVH Stock Holding History

Caption Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,000
Closed -$169K – 1721
2025
Q3 		$169K Hold
20,000
– – ﹤0.01% 1490
2025
Q2 		$225K Sell
20,000
-17,829
-47% -$164K ﹤0.01% 1246
2025
Q1 		$358K Sell
37,829
-41,143
-52% -$416K ﹤0.01% 1175
2024
Q4 		$888K Buy
78,972
+78,958
+563,986% +$1.39M 0.01% 953
2024
Q3 		$396 Sell
14
-82,197
-100% -$2.12M ﹤0.01% 1225
2024
Q2 		$1.57M Buy
+82,211
New +$2.1M 0.02% 539
2024
Q1 		– Sell
-2,500
Closed -$79.8K – 1339
2023
Q4 		$82.6K Buy
+2,500
New +$70.7K ﹤0.01% 1193
2023
Q1 		– Sell
-20,313
Closed -$570K – 1224
2022
Q4 		$570K Buy
+20,313
New +$582K 0.01% 891
2021
Q4 		– Sell
-25,000
Closed -$775K – 1692
2021
Q3 		$775K Buy
+25,000
New +$600K 0.01% 1102
2020
Q4 		– Sell
-47,000
Closed -$583K – 1064
2020
Q3 		$583K Buy
+47,000
New +$553K 0.01% 740
2019
Q4 		– Sell
-67,200
Closed -$484K – 882
2019
Q3 		$484K Buy
67,200
+52,700
+363% +$378K 0.03% 489
2019
Q2 		$115K Buy
+14,500
New +$172K 0.01% 598

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Caption Management's EVH Position: Q4 2025 in Review

Caption Management sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 20,000 shares — an estimated $169K sold.

Caption Management first reported a position in EVH in Q2 2019 and held it in 12 quarters. The position peaked at $1.57M in Q2 2024. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • Caption Management reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 20,000 Evolent Health shares in Q4 2025, an estimated $169K.
  • Caption Management first reported a position in Evolent Health in Q2 2019 and held it in 12 quarters.
  • Caption Management's Evolent Health position peaked at $1.57M in Q2 2024.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.